1. T. Ghose and A.H. Blair, Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects, JNCI 61: 657 (1978).
2. K.R. McIntire, Tumor markers for radioimmunodetection of cancer, Cancer Res. 40: 3083 (1980).
3. T. Ghose, A.H. Blair, K. Vaughan, and P. Kulkarni, Antibody-directed drug targeting in cancer, in: “Targeted Drugs Polymers in Biology and Medicin,” Vol. 2, E. Goldberg, L. Donaruma and O. Vogl, eds., John Wiley and Sons, Inc., New York (in press).
4. T. Ghose, A.H. Blair, R.H. Martin, S.T. Norvell, S. Ramakrish- nan, and P. Belitsky, Tumor imaging by antitumor antibody-linked radionuclides, in: “Tumor Imaging: the Radiochemical Detection of Cancer,” S. Burchiel and B.A. Rhodes, eds., Masson Publishing U.S.A., Inc., New York (in press).
5. T. Ghose, S.T. Norvell, J. Aquino, P. Belitsky, J. Tai, A. Guclu, and A.H. Blair, Localization of 131I-labeled antibodies in human renal cell carcinomas and a mouse hepatoma and correlation with tumor detection by photoscanning, Cancer Res. 40: 3018 (1980).